E2F1 and KIAA0191 expression predicts breast cancer patient survival

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Hallett, Robin M ^a   Hassell, John A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79953230908     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-95     Document Type: Article

References (27)

1. Gene-expression signatures in breast cancer. C Sotiriou LC Pusztai, N Engl J Med 2009 360 8 790 800 10.1056/NEJMra0801289 19228622
2. A gene-expression signature as a predictor of survival in breast cancer. MJ van de Vijver YD He LJ van't Veer H Dai AA Hart DW Voskuil GJ Schreiber JL Peterse C Roberts MJ Marton,, et al. N Engl J Med 2002 347 25 1999 2009 10.1056/NEJMoa021967 12490681 (Pubitemid 35461656)
3. Gene expression profiling predicts clinical outcome of breast cancer. LJ van 't Veer H Dai MJ van de Vijver YD He AA Hart M Mao HL Peterse K van der Kooy MJ Marton AT Witteveen,, et al. Nature 2002 415 6871 530 536 11823860 (Pubitemid 34130608)
4. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. S Paik S Shak G Tang C Kim J Baker M Cronin FL Baehner MG Walker D Watson T Park,, et al. N Engl J Med 2004 351 27 2817 2826 10.1056/NEJMoa041588 15591335 (Pubitemid 40051905)
5. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. C Sotiriou P Wirapati S Loi A Harris S Fox J Smeds H Nordgren P Farmer V Praz B Haibe-Kains,, et al. J Natl Cancer Inst 2006 98 4 262 272 10.1093/jnci/djj052 16478745 (Pubitemid 43264710)
6. Distinct roles for E2F proteins in cell growth control and apoptosis. J DeGregori G Leone A Miron L Jakoi JR Nevins, Proc Natl Acad Sci USA 1997 94 14 7245 7250 10.1073/pnas.94.14.7245 9207076 (Pubitemid 27345300)
7. E2F - at the crossroads of life and death. S Polager D Ginsberg, Trends Cell Biol 2008 18 11 528 535 10.1016/j.tcb.2008.08.003 18805009
8. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. J DeGregori T Kowalik JR Nevins, Mol Cell Biol 1995 15 8 4215 4224 7623816
9. Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis. J DeGregori DG Johnson, Curr Mol Med 2006 6 7 739 748 17100600 (Pubitemid 44725567)
10. An algorithm to discover gene signatures with predictive potential. RM Hallett A Dvorkin CM Gabardo JA Hassell, J Exp Clin Cancer Res 29 1 120 10.1186/1756-9966-29-120 20813028
11. TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. I Heo C Joo YK Kim M Ha MJ Yoon J Cho KH Yeom J Han VN Kim, Cell 2009 138 4 696 708 10.1016/j.cell.2009.08.002 19703396
12. Evaluating the yield of medical tests. FE Harrell Jr RM Califf DB Pryor KL Lee RA Rosati, JAMA 1982 247 18 2543 2546 10.1001/jama.247.18.2543 7069920 (Pubitemid 12155954)
13. Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome. V Vuaroqueaux P Urban M Labuhn M Delorenzi P Wirapati CC Benz R Flury H Dieterich F Spyratos U Eppenberger,, et al. Breast Cancer Res 2007 9 3 33 10.1186/bcr1681 17535433
14. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. AV Ivshina J George O Senko B Mow TC Putti J Smeds T Lindahl Y Pawitan P Hall H Nordgren,, et al. Cancer Res 2006 66 21 10292 10301 10.1158/0008-5472.CAN-05-4414 17079448 (Pubitemid 44799747)
15. Introduction to the E2F family: protein structure and gene regulation. JE Slansky PJ Farnham, Curr Top Microbiol Immunol 1996 208 1 30 8575210
16. A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. H Dai L van't Veer J Lamb YD He M Mao BM Fine R Bernards M van de Vijver P Deutsch A Sachs,, et al. Cancer Res 2005 65 10 4059 4066 10.1158/0008-5472.CAN-04-3953 15899795 (Pubitemid 40775642)
17. Bub1 regulates chromosome segregation in a kinetochore-independent manner. C Klebig D Korinth P Meraldi, J Cell Biol 2009 185 5 841 858 10.1083/jcb.200902128 19487456
18. A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all? B Haibe-Kains C Desmedt C Sotiriou G Bontempi, Bioinformatics 2008 24 19 2200 2208 10.1093/bioinformatics/btn374 18635567
19. Bub1: escapades in a cellular world. GL Williams TM Roberts OV Gjoerup, Cell Cycle 2007 6 14 1699 1704 10.4161/cc.6.14.4493 17643075 (Pubitemid 47327921)
20. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. H Zhou J Kuang L Zhong WL Kuo JW Gray A Sahin BR Brinkley S Sen, Nat Genet 1998 20 2 189 193 10.1038/2496 9771714 (Pubitemid 28455454)
21. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. B Fisher J Costantino C Redmond R Poisson D Bowman J Couture NV Dimitrov N Wolmark DL Wickerham ER Fisher,, et al. N Engl J Med 1989 320 8 479 484 10.1056/NEJM198902233200802 2644532 (Pubitemid 19062522)
22. Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. B Fisher J Dignam N Wolmark A DeCillis B Emir DL Wickerham J Bryant NV Dimitrov N Abramson JN Atkins,, et al. J Natl Cancer Inst 1997 89 22 1673 1682 10.1093/jnci/89.22.1673 9390536 (Pubitemid 27508191)
23. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. B Fisher JH Jeong J Bryant S Anderson J Dignam ER Fisher N Wolmark, Lancet 2004 364 9437 858 868 10.1016/S0140-6736(04) 16981-X 15351193 (Pubitemid 39221063)
24. Bub1 is essential for assembly of the functional inner centromere. Y Boyarchuk A Salic M Dasso A Arnaoutov, J Cell Biol 2007 176 7 919 928 10.1083/jcb.200609044 17389228 (Pubitemid 46506966)
25. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. DC Allred JM Harvey M Berardo GM Clark, Mod Pathol 1998 11 2 155 168 9504686 (Pubitemid 28144151)
26. Gene-expression-based prognostic assays for breast cancer. C Kim S Paik, Nat Rev Clin Oncol 7 6 340 347 10.1038/nrclinonc.2010.61 20440284
27. How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Y Guo P Xiao S Lei F Deng GG Xiao Y Liu X Chen L Li S Wu Y Chen,, et al. Acta Biochim Biophys Sin (Shanghai) 2008 40 5 426 436 10.1111/j.1745-7270.2008.00418.x 18465028 (Pubitemid 351704046)